Dr. Baron-Hay is a medical oncologist specializing the management of women diagnosed with Breast and Gynaecological cancer at Royal North Shore Hospital, Sydney and Genesis Care, Sydney. Dr Baron-Hay completed her undergraduate training at the University of Western Australia before travelling to London, UK where she worked at the Royal Marsden Hospital in South Kensington establishing her career in Oncology working in the Early Phase trials unit. She completed her physician training at Royal North Shore Hospital and Royal Prince Alfred Hospital. Her early basic research through the Kolling Institute examined the Role of Insulin Like Growth Factors in the pathogenesis of Ovarian Cancer for which was awarded a NHMRC fellowship. Her main interests now include the management of women diagnosed with Breast and Ovarian Cancer and she is the head of the clinical trials unit in these 2 cancer streams at RNSH. She is the PI on both early phase 1/11 and Phase III trials. She was a AI on the “Chemotherapy-Induced Peripheral Neuropathy: assessment strategies, treatments and Risk Factors” 2015 Translational Cancer Grant Program NSW Cancer Institute and is an AI on the “INOVATe-Individualised ovarian. Cancer treatment through integration of genomic pathology into multidisciplinary Care”, initial grant 2015-2019, extended 2020. DR Baron-Hay is a member of the Ovarian Cancer tumour working Group at the ANZGOG. Dr Baron-Hay is a member of the eviQ medical oncology reference committee for both breast and Gynaecological Malignancies. She attends weekly Multidisciplinary meetings in both Breast and Gynaecological malignancies at RNSH, implementing multidisciplinary approached to patient care. She is a supervisor of medical oncology advanced trainees through RNSH and a lecturer in medical oncology for medical students through University of Sydney. She has been involved in both face to face and virtual educational lectures during her appointment at RNSH.